【レポートの概要（一部）】
1. Report Overview
1.1 Global Translational Regenerative Medicine: Market Overview
1.2 Global Translational Regenerative Medicine Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered By This Analytical Report
1.6 Who Is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. An Introduction To Translational Regenerative Medicine
2.1 What is Regenerative Medicine?
2.1.1 Translational Regenerative Medicine – From Bench To Bedside
2.2 Translational Regenerative Medicine – Market Breakdown
2.2.1 Stem Cell Therapy – Marketable Differentiation And Specialisation
2.2.1.1 How Embryonic Stem Cells (ESCs) Entered The Fray
2.2.1.2 Classifying Stem Cells by Potency
2.2.1.3 Stem Cells Categories: ESCs, SSCs, iPSCs
2.2.1.4 Parthenogenetic Stem Cells: Ethical ESC-Like Cells?
2.2.1.5 Autologous versus Allogeneic Stem Cells: Towards Universal Stem Cell Products?
2.2.2 Tissue Engineering – Invitro Manipulation For Therapeutic Purposes
2.2.3 Gene Therapies
2.2.3.1 Harnessing Infectivity: Viral Vectors in Gene Therapy
2.3 Other Approaches To Regenerative Medicine
2.3.1 Small Molecules and Proteins – Scaffold-Based Delivery Of Signalling Molecules
2.3.2 Cosmetic Applications of Regenerative Medicine
2.4 Regulation of Regenerative Medicine
2.4.1 Regulation of Regenerative Medicine Products in Europe
2.4.2 Regulation of Regenerative Medicine Products in the US
2.5 The Phases of Clinical Trials
2.6 Market Definition
2.6.1 Products Excluded From The Report
3. Translational Regenerative Medicine Market, 2015-2025
3.1 Global Translational Regenerative Medicine: Market Overview
3.1.1 Segments Within The Global Translational Regenerative Medicine Market
3.2 The Global Translational Regenerative Medicine Market In 2013 And 2014
3.3 Global Translational Regenerative Medicine: Market Forecast 2015-2025
3.3.1 Market Sectors That Will Drive Regenerative Medicine Growth
3.3.2 Global Translational Regenerative Medicine Market – Changing Market Shares By Sector 2015-2025
4. Stem Cell Therapies: Leading Applications, 2015-2025
4.1 The Global Market For Stem Cell Therapies, 2013 And 2014
4.1.1 Stem Cell Therapies: Currently Available Therapies
4.1.2 Haematopoietic Stem Cell Transplantation (HSCT)
4.1.3 Stem Cell Orthobiologics
4.2 Stem Cell Therapies: Global Market Forecast 2015-2025
4.3 AlloStem (AlloSource)
4.4 Osteocel Plus (NuVasive)
4.4.1 Osteocel Plus: Sales Forecast 2015-2025
4.5 Trinity ELITE and Trinity Evolution (Orthofix)
4.5.1 Trinity ELITE and Trinity Evolution: Sales Forecast, 2015-2025
4.6 PureGen (AlphaTec Spine)
4.7 Other Approved Stem Cell Therapy Products, 2015
4.7.1 Cartistem (Medipost)
4.7.2 Cupistem (Anterogen)
4.7.3 Hearticellgram-AMI (Pharmicell)
4.7.4 Prochymal/ Remestemcel-L (Mesoblast)
4.7.4.1 Prochymal/ Remestemcel-L: Sales Forecast 2015-2025
4.8 Development Pipeline For Stem Cell Therapies, 2015-2025
4.8.1 Late-Stage Pipeline for Stem Cell Therapies, 2015
4.8.1.1 StemEx (Gamida Cell)
4.8.1.2 Mesenchymal Precursor Cell Therapies (Mesoblast)
4.8.1.3 Adult Autologous CD34+ Cells (Baxter)
4.8.1.4 MyoCell (Bioheart)
4.8.1.5 Cx601 (TiGenix)
4.8.1.6 Adipose-Derived Stem Cells (Cytori Therapeutics)
4.8.1.7 Stempeucel (Stempeutics Research)
4.8.1.8 C-Cure (Cardio3 BioSciences)
4.8.1.9 Other Late-Stage Stem Cell Therapies
4.8.2 Diabetes And Stem Cell Therapy
4.8.2.1 Mesenchymal Precursor Cells (Mesoblast)
4.8.2.2 VC-01 (ViaCyte Inc)
4.8.2.2.1 Clinical Development Efforts For VC-01 For The Treatment Of Diabetes
4.8.3 Cardiovascular Disease And Stem Cell Therapy
4.8.3.1 Endometrial Regenerative Cells (MediStem, Intrexon)
4.8.3.2 AMR-001 (NeoStem)
4.8.3.3 CAP-1002 (Capricor)
4.8.4 Stem Cell Therapy in Cancer
4.8.4.1 CLT-008 (Cellerant Therapeutics)
4.8.4.2 OncoCyte/BioTime – Targeting Cancer With Gene And Stem Cell Therapy
4.8.5 Stem Cell Therapy For Central Nervous System (CNS) Conditions
4.8.5.1 NurOwn (BrainStorm Cell Therapeutics)
4.8.5.1.1 Clinical Development Efforts for NorOwn, 2015
4.8.5.2 NSI-566 (Neuralstem)
4.8.5.3 MultiStem (Athersys)
4.8.5.4 PDA-001 (Cenplacel-L, Celgene)
4.8.5.5 ALD-401 (Cytomedix)
4.8.5.6 ReN001 (ReNeuron)
4.8.6 Stem Cell Therapy for Eye Diseases
4.8.6.1 MA09-hRPE (Advanced Cell Technology)
4.8.6.2 HuCNS-SC (StemCells Inc.)
4.8.6.3 Collaboration And License Agreement Between Pfizer And The London Project to Cure Blindness
4.9 Stem Cells Therapy Market: Drivers and Restraints 2015-2025
5. Tissue Engineering Therapies: Leading Applications, 2015-2025
5.1 The Global Market For Tissue Engineered Therapies, 2013 And 2014
5.1.1 Tissue Engineering Therapies: Currently Available Therapies
5.2 Tissue Engineering Therapies: Global Market Forecast 2015-2025
5.3 Tissue Engineering In Wound Repair And Healing
5.3.1 Apligraf (Organogenesis)
5.3.1.1 Apligraf: Historical Sales Analysis
5.3.1.2 Apligraf: Sales Forecast 2015-2025
5.3.2 BioDfence and BioDfactor (BioD)
5.3.3 CureXcell (MacroCure)
5.3.4 Dermagraft (Organogenesis)
5.3.4.1 Dermagraft (Shire): Sales Forecast 2015-2025
5.3.5 Epicel (Aastrom)
5.3.6 Grafix (Osiris Therapeutics)
5.3.7 MySkin and CyroSkin (Regenerys)
5.3.8 ReCell (Avita Medical)
5.3.8.1 ReCell (Avita Medical): Sales Forecast 2015-2025
5.4 Tissue Engineering for Cartilage Repair
5.4.1 Autologous Chondrocyte Implantation (ACI)
5.4.2 Carticel (Aastrom Biosciences)
5.4.3 ChondroCelect (TiGenix, Sobi Partners)
5.4.4 DeNovo NT (Zimmer)
5.4.5 MACI (Aastrom Biosciences)
5.5 Other Available Tissue Engineering Therapies
5.5.1 Autologous Cultured Cell and Tissue Products (Japan Tissue Engineering Co.)
5.5.2 Gintuit (Organogenesis)
5.5.3 LAVIV (azficel-T), (Fibrocell Science)
5.5.4 Acellular Tissue Engineering Products
5.6 Tissue Engineering: Development Pipeline, 2015-2025
5.6.1 Pipeline Products For Autologous Chondrocyte Implantation
5.6.2 Tissue Engineering For Skin
5.6.3 Tissue Engineering for Liver Diseases
5.6.3.1 Extracorporeal Bio-Artificial Liver Therapy (Vital Therapies)
5.6.4 Tissue Engineering for Cardiovascular Disease
5.6.5 Tissue Engineering for Eye Diseases
5.7 Future Prospects for Organ Transplantation and Tissue Engineering
5.8 Tissue Engineered Products Market: Drivers and Restraints 2015-2025
6. Gene Therapies: Leading Applications, 2015-2025
6.1 The Global Market For Gene Therapies, 2013 And 2014
6.2 Gene Therapies: Global Market Forecast 2015-2025
6.3 Currently Available Gene Therapy Products
6.3.1 Gendicine (Benda Pharmaceutical)
6.3.2 Oncorine (Shanghai Sunway Biotech)
6.3.3 Neovasculgen (Human Stem Cells Institute)
6.3.3.1 Neovasculgen (HSCI): Sales Forecast 2015-2025
6.3.4 Glybera (UniQure)
6.3.4.1 Glybera: Sales Forecast 2015-2025
6.4 Development Pipeline For Gene Therapies, 2015-2025
6.4.1 Late-Stage Pipeline Gene Therapies, 2015
6.4.1.1 Collategene (beperminogene perplasmid) – (AnGes MG/Vical)
6.4.1.2 ProstAtak (AdV-tk) – (Advantagene)
6.4.1.3 Trinam (taberminogene vadenovec) – (Ark Therapeutics)
6.4.1.4 T-VEC (talimogene laherparepvec) – (Amgen)
6.4.1.4.1 Clinical Trials And Development Efforts For T-Vec
6.4.1.4.2 Talimogene Laherparepvec (T-Vec) – Sales Forecast 2015-2025
6.4.1.5 AAV2-hRPE65v2 (Spark Therapeutics)
6.4.1.6 CG0070 (Cold Genesys)
6.4.2 Gene Therapy For Use In The Treatment Of Diabetes
6.4.3 Gene Therapy Directed At Oncology Indications
6.4.4 Gene Therapy Directed At Neurological Diseases
6.4.5 Gene Therapy Directed At Tackling Haemophilia B
6.5 Gene Therapy Market: Drivers and Restraints 2015-2025
7. Leading National Markets for Translational Regenerative Medicine, 2015-2025
7.1 The Translational Regenerative Medicine Market By Region
7.1.1 The Global Distribution of Translational Regenerative Medicine In 2013 And 2014
7.2 Leading National Markets: Forecast 2015-2025
7.2.1 Changing Market Shares By Region, 2015-2025
7.3 Regional Translational Regenerative Medicine Markets: Analysis And Forecasts, 2015-2025
7.4 United States: The Largest Translational Regenerative Medicine Market
7.4.1 US Translational Regenerative Medicine Market: Market Drivers And Restraints, 2015-2025
7.4.2 US Translational Regenerative Medicine Market: Market Forecast 2015-2025
7.4.3 The Regulatory Framework For Regenerative Medicine In The US
7.4.4 The Impact Of Ethical And Regulatory Reluctance To Embryonic Stem Cell Research And Its Impact On Funding
7.4.5 How Is The Ending Of Patenting For Human Gene Products Affecting The Regenerative Medicine Market In The US?
7.5 Europe: A Fragmented Regenerative Medicine Market
7.5.1 European Regenerative Medicine Market: Market Drivers and Restraints, 2015-2025
7.5.2 European Regenerative Medicine Market: Market Forecast 2015-2025
7.5.3 Europe’s Unitary Patent System And Its Impact On The Future Of Regenerative Medicine In The Region
7.5.4 Regulation Of Regenerative Medicine In The European Union
7.5.5 UK: A Leading Research Centre For Regenerative Medicine In Europe
7.5.5.1 Regulation of Stem Cell Research In The UK
7.5.6 Russia: Rising Interest In Regenerative Medicine Research
7.6 Asia-Pacific: Accommodating Regulatory Landscape Aiding Rapid Product Commercialisation
7.6.1 Asia-Pacific Regenerative Medicine Market: Market Drivers and Restraints, 2015-2025
7.6.2 Asia-Pacific Regenerative Medicine Market: Market Forecast 2015-2025
7.6.3 Australia: Encouraging Translational Regenerative Medicine
7.6.4 China: Encouraging Stem Cell R&D
7.6.4.1 Government Intervention Into RM Research In China
7.6.4.2 Regulation Of Stem Cell Research In China
7.6.4.3 Commercialisation Of Gene Therapy And Tissue Engineering Products In China
7.6.4.4 Medical Tourism Impacting Market Growth For Regenerative Medicine In China
7.6.5 Japan: Difficulty In Translating Research Into Commercialisation
7.6.5.1 Research Funding: A Major Determinant Of Growth In Japan’s Regenerative Medicine
7.6.5.2 Government Interventions In Promoting Stem Cell Research In Japan
7.6.5.3 Regulation of Regenerative Medicine In Japan
7.6.6 India: An Emerging Market For Regenerative Medicine
7.6.6.1 Efforts In Stem Cell Research In India
7.6.6.2 Unclear Guidelines Hindering Progression Of Gene Therapy Research In India
7.6.7 South Korea: First to Approve Stem Cell Treatments
7.6.7.1 A Regeneration In South Korea’s Stem Cell Research Efforts
7.7 Rest of the World: Regenerative Medicine Conquering New Territories And Booming
7.7.1 Rest of the World Regenerative Medicine Market: Market Forecast 2015-2025
8. Leading Companies In The Translational Regenerative Medicine Market, 2015-2025
8.1 Translational Regenerative Medicine: A Hotbed For Innovation
8.2 Aastrom Biosciences
8.2.1 Aastrom’s Acquisition Of Sanofi’s Regenerative Medicine Business
8.2.2 Aastrom: Historical Financial And Performance Analysis, 2011-2013
8.2.3 Aastrom Regenerative Medicine Portfolio, 2015
8.2.4 Aastrom: Pipeline Analysis, 2015
8.3 Alphatec Spine
8.3.1 Alphatec Spine: Financial And Performance Analysis, 2009-2013
8.3.2 Alphatec Spine’s Shifting Focus From Regenerative Medicine To Medical Devices
8.4 Anterogen
8.4.1 Anterogen: Pipeline Analysis, 2015
8.5 Athersys
8.5.1 Athersys: Financial And Performance Analysis, 2010-2013
8.5.2 Athersys: Pipeline Analysis, 2015
8.5.2.1 MultiStem Technology – Potential Treatment For A Range Of Diseases
8.6 Avita Medical
8.6.1 Avita Medical: Historical Financial And Performance Analysis, 2013-2014
8.6.2 Avita Medical: Regenerative Medicine Portfolio, 2015
8.6.3 Avita Medical: Pipeline Analysis, 2015
8.7 AxoGen
8.7.1 AxoGen: Historical Financial And Performance Analysis, 2010-2013
8.7.2 AxoGen: Regenerative Medicine Portfolio, 2015
8.7.3 AxoGen: Pipeline Analysis, 2015
8.8 Medipost
8.8.1 Medipost: Historical Financial And Performance Analysis, 2011-2013
8.8.2 Medipost: Regenerative Medicine Portfolio, 2015
8.8.3 Medipost: Pipeline Analysis, 2015
8.9 Mesoblast
8.9.1 Mesoblast Product Portfolio, 2015
8.9.2 Mesoblast: Historical Financial And Performance Analysis, 2011-2014
8.9.3 Mesoblast: Pipeline Analysis, 2015
8.9.3.1 NeoFuse
8.9.3.2 Chondrogen
8.9.3.3 Prochymal
8.9.3.4 Other Recent Pipeline Acquisitions By Mesoblast
8.10 NuVasive
8.10.1 NuVasive Product Portfolio, 2015
8.10.2 NuVasive: Historical Financial And Performance Analysis, 2009-2013
8.10.3 NuVasive: Pipeline Analysis, 2015
8.11 Ocata Therapeutics
8.11.1 Ocata Therapeutics: Historical Financial And Performance Analysis, 2009-2013
8.11.2 Ocata Therapeutics: Pipeline Analysis, 2015
8.11.2.1 Retinal Pigment Epithelial Cell Therapy
8.11.2.2 Research Around iPSC-derived Platelets
8.11.2.3 Hemangioblast As A Treatment for Blood And Cardiovascular Diseases
8.11.2.4 Mesenchymal Stem Cell Program – Tissue Repair Functionalities
8.11.3 Ocata’s Other Therapeutic Platforms
8.12 Organogenesis
8.12.1 Organogenesis RM Portfolio, 2015
8.12.2 Organogenesis: Pipeline Analysis, 2015
8.13 Osiris Therapeutics
8.13.1 Osiris Therapeutics: RM Portfolio, 2015
8.13.2 Osiris Therapeutics: Historical Financial And Performance Analysis, 2010-2013
8.13.3 Osiris Therapeutics: Pipeline Analysis, 2015
8.14 Pharmicell
8.14.1 Pharmicell: Historical Financial And Performance Analysis, 2011-2013
8.14.2 Pharmicell: Pipeline Analysis, 2015
8.15 Regenerys
8.15.1 Regenerys: RM Portfolio, 2015
8.15.2 Regenerys: Pipeline Analysis, 2015
8.16 Shire
8.16.1 Shire: RM Portfolio, 2015
8.16.2 Shire: Historical Financial And Performance Analysis, 2010-2013
8.16.3 Shire: Pipeline Analysis, 2015
8.16.3.1 Vascugel
8.17 TiGenix
8.17.1 TiGenix: Historical Financial And Performance Analysis, 2011-2013
8.17.2 TiGenix: Pipeline Analysis, 2015
8.18 UniQure
8.18.1 UniQure: Pipeline Analysis, 2015
9. Qualitative Analysis for the Global Translational Regenerative Medicine Market, 2015-2025
9.1 Market Factors Influencing The Translational Regenerative Medicine Market
9.2 SWOT Analysis Of The Translation Market, 2015-2025
9.2.1 Strengths
9.2.1.1 Improvements In Regulatory Frameworks
9.2.1.2 Advancements In General Cellular And Tissue Research Aiding Regenerative Medicine
9.2.1.3 Strong Support From Governments In Multiple Regions
9.2.1.4 Increasing Ease Of Product Commercialisation And Market Access
9.2.2 Weaknesses
9.2.2.1 The High Price Of Regenerative Medicine Products May Restrain Market Growth
9.2.2.2 Lack Of Funding From Venture Capital
9.2.2.3 The Intrinsic Lack Of Standardisation Is A Burden To Scaling Up Manufacturing
9.2.2.4 Successful Commercialisation Of RM Products Requires New Business Models
9.2.3 Opportunities
9.2.3.1 3D Bioprinting And Other Technologies May Enable Rapid Scale-Up
9.2.3.2 Medical Tourism May Stimulate Standardisation And Drive Market Growth
9.2.3.3 Disruptive Regenerative Medicine Therapies Can Create New Markets
9.2.4 Threats
9.2.4.1 Ethical Concerns Limiting R&D In Regenerative Medicine
9.2.4.2 Difficulty Establishing An Evidence Base For Long-Term Efficacy Of RM Therapies
9.2.4.3 Rate Of Scientific Progress – A Major Determinant Of RM Market Growth
9.2.4.4 Restraints On Reimbursement May Slow Growth
9.3 Porter’s Five Force Analysis Of The Translational Regenerative Medicine Market, 2015-2025
9.3.1 Threat Of New Entrants
9.3.2 Threat Of Substitutes
9.3.3 Power Of Suppliers
9.3.4 Power Of Buyers
9.3.5 Rivalry Among Competitors
10. Expert Opinions from Our Primary Research
10.1 Interview With Antonio S J Lee Ph.D, CEO & Managing Director For MEDIPOST America Inc.
10.1.1 MEDIPOST And Recent Developments In Regenerative Medicine
10.1.2 The Transition From Mid- To Late-Stage Clinical Trials In The RM Market And Its Likely Implications
10.1.3 CARTISTEM®, PNEUMOSTEM®, NEUROSTEM® – Medipost’s Development Plans In Regenerative Medicine
10.1.4 Cord Blood Banking And Korea’s Role In Its Advancement
10.1.5 The Role Of R&D Strategies And Long-Term Efficacy Data In The Future Success Of Regenerative Medicine
10.1.6 The Role Of Big-Pharma Companies In Regenerative Medicine And The Need For Regulatory Harmonisation
10.1.7 On The Unmet Needs For Regenerative Medicine To Target
10.1.8 On The Future Developments To Expect In The Market For Regenerative Medicine Over The Next Decade
11. Conclusions
11.1 Overview Of Current Market Conditions And Market Forecast, 2013-2025
11.2 Leading Regenerative Medicine Segments In 2013
11.3 Leading Regions In The Translational Regenerative Medicine Market In 2013 And 2014
11.4 Future Outlook For The Various Sectors Within TRM, 2015-2025
11.5 R&D Pipeline Products Crucial To Future Market Growth
11.6 What Does The Future Hold For Regenerative Medicine?
【レポート販売概要】
■ タイトル：トランスレーショナル再生医療の世界市場：幹細胞治療、ティッシュ・エンジニアリング治療、遺伝子治療■ 英文：Translational Regenerative Medicine: Market Prospects 2015-2025
■ 発行日：2015年2月
■ 調査会社：visiongain
■ 商品コード：VGAIN5020411
■ 調査対象地域：世界
- シアン化ナトリウムの世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world sodium cyanide market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true in …
- 世界における主要なモバイルヘルス（mHealth）企業分析：モバイル健康管理、遠隔医療、eヘルス、遠隔患者モニタリングThe advent of connected devices and M2M is offering a tremendous opportunity for healthcare professionals. Near-ubiquitous mobile networks are allowing carers to diagnose, monitor, and communicate with patients with unprecedented speed and efficacy. MHealth is a term used for the practice of medicine and health services, through mobile devices. In its most common form, it refers to using mobile co …
- 農業用ロボットの世界市場2015-2019About agricultural robots Agricultural robots are used in agricultural activities such as livestock management, cattle feeding, cleaning, and wildlife conservation. These robots decrease the dependency of farmers on labor, thus reducing the labor costs. They also help in increasing agricultural productivity. Technavio's analysts forecast the global agricultural robots market to grow at a CAGR of 1 …
- 世界のバイオマス市場動向Over the years to come, biomass will grow within the biopower, biofuels, and bioproduct sectors. The market value of electricity generated from biomass in the United States was over $45 billion in 2011. About 70% of all biomass in the world is used in the residential sector, while 14% is used in industry and 11% is transformed into electricity, heat, or another energy carrier such as liquid fuel o …
- 世界の受動光ネットワーク(PON)装置市場2015The Global Passive Optical Network (PON) Equipment Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Passive Optical Network (PON) Equipment industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Passive Optical Network (PON) Equipment market analysis is …
- 世界のグリーン建設（緑の建築）市場動向• The report presents an in-depth analysis of industry executives’ opinions about the adoption of green construction • The report identifies key reasons for companies not to undertake green construction projects • The report highlights the key priorities of industry executives with regards to the transformation of green construction activities in their future construction projects • The report asc …
- HDPEパイプのインド市場：製品タイプ別（標準ダクト、マイクロダクト、パスウェイ、その他）、業種別（テレコム、電力、輸送、建築、インフラストラクチャ、その他）、アプリケーションエリア別（バックボーン、メトロポリタン、モバイルバックホール）The India HDPE Pipes Market for FTTx Industry accounted for $99.9 million in 2018, and is anticipated to reach $233.5 million by 2026, registering a CAGR of 11.2% from 2019 to 2026. High density polyethylene (HDPE) pipes are made from graded raw materials such as PE 63, PE 80, and PE 100. HDPE pipes are one of the most sought-after mediums of conveying and transporting chemicals, water, and gases. …
- 世界のモバイル及びオンライン決済市場This report gives an overview of the mobile and online payment market. It provides the main figures for each market segment (in-store payment, carrier billing, remote online payment). The latest market trends are analyzed, as well as the position and evolution of the main players (especially telcos and Internet players).
- 飲料用カートン包装機械の世界市場予測（～2022年）“The beverage carton packaging machinery market is projected to grow at a CAGR of 2.39% from 2017 to 2022” The beverage carton packaging machinery market is estimated at USD 746.9 million in 2017 and is projected to reach USD 840.7 million by 2022, at a CAGR of 2.39%. The increasing consumption of beverages, mainly alcoholic drinks such as beer and vodka, drives the market for beverage packaging. …
- 特殊ポリアミドの世界市場分析：用途別（自動車/輸送、電気・電子、消費財・小売、エネルギー、工業用コーティング）、競争戦略、動向分析、セグメント予測、2014 – 2024The global specialty polyamides market is expected to reach USD 3.28 billion by 2024, according to a new report by Grand View Research, Inc. Rising utilization of eco-friendly nylon materials that offers high efficiency and protection to extend product durability is projected to boost market demand over the forecast period. Growing environmental concern shave led to rise in interest to develop pol …
- せん妄(Delirium)：世界の治験レビュー（2015年上半期版）Delirium Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Delirium Global Clinical Trials Review, H1, 2015" provides data on the Delirium clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Delirium. It includes an overview of the trial numbers and their recruitment status as per the site of trial condu …
- クメンの世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world Cumene market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true insight in …
- イギリスの分子診断・検査市場2014This report provides an overview of the UK molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.Table of ContentsBusiness Environment Market Structure Market Size, Growth, and Major Suppliers' Market Shares List of TablesMolecular …
- 外国為替（FX）の世界市場：通貨スワップ、アウトライト取引、FXスワップ、FXオプションAbout the Foreign Exchange Market Foreign exchange markets remained robust during the 2007 financial crisis. The advent of electronic platforms has significantly boosted day-to-day trading volumes, which generates higher levels of market returns, that have remained uncorrelated compared to the different trading markets across the world. Widespread electronic trading permits anonymous market practi …
- ホブ盤の世界市場2017-2021About Gear Hobbing Machine The manufacturing process used to cut tooth type geometries is known as hobbing. Hobbing is an important industrial process for gear manufacturing. The process is carried out using a hobbing machine with two skew spindles, one of these spindles is mounted with the hob while the other is mounted with a blank workpiece. Hobbing machines or hobbers, as they are commonly kno …
